BILLERICA, Mass. – Insulet Corp. has received clearance from the U.S. Food and Drug Administration for its Omnipod DASH Insulin Management System. The Omnipod DASH features an easy-to-read, touch-screen PDM; user-friendly steps to manage basal rates; and a food library.
ARLINGTON, Va. – The American Diabetes Association on May 24 released a public policy statement outlining both long- and short-term recommendations for improving insulin access and affordability.
TORONTO – Inolife R&D has entered into a letter of intent with ADW Diabetes for the distribution of its Inojex, a patented and FDA-cleared needle-free injection device.
FLETCHER, N.C. – A new tool that connects DME providers with a nationwide network of certified shoe fitters aims to help providers kick-start a therapeutic shoe business without having to incur a lot of expense, says Marcus Suess.
NEW YORK – One Drop’s primary goal has always been to give people with diabetes a place to collect all of the data that matters to them, says Rachel Sanchez, marketing associate.
ABBOTT PARK, Ill. – The FreeStyle Libre System is the second continuous glucose monitoring system approved for Medicare coverage. The Abbott-manufactured system requires no user calibration, reading glucose levels via a sensor worn on the upper arm.
WASHINGTON – CMS has proposed revising the definitions of custom fabricated and therapeutic inserts in Appendix C of the DMEPOS Quality Standards to account for new technology.
Among the patient population with chronic illnesses, diabetes is the most common catalyst and comorbidity, which makes it one of the most complex and important disorders facing providers. And its growth, gradually rising for decades, continues unabated.
